Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
27
28
30
1
2
3
4
5
6
7
8
9
11
12
13
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Forbes Healthcare Summit
2017-11-29 - 2017-11-30    
All Day
ForbesLive leverages unique access to the world’s most influential leaders, policy-makers, entrepreneurs, and artists—uniting these global forces to harness their collective knowledge, address today’s critical [...]
29th Annual National Forum on Quality Improvement in Health Care
2017-12-10 - 2017-12-13    
All Day
PROGRAM OVERVIEW The IHI National Forum on December 10–13​, 2017, will bring more than 5,000 brilliant minds in health care to Orla​​ndo, Florida, to find meaningful connections [...]
Dallas Health IT Summit
2017-12-14 - 2017-12-15    
All Day
About Health IT Summits U.S. healthcare is at an inflection point right now, as policy mandates and internal healthcare system reform begin to take hold, [...]
Events on 2017-11-29
Forbes Healthcare Summit
29 Nov 17
New York
Events on 2017-12-14
Dallas Health IT Summit
14 Dec 17
Dallas
Articles

Apr 05: Effects of EHR-based interventions on cervical cancer screening in adolescents

medicare ehr payments

White P, et al. – Researchers sought to determine whether the 2011 electronic health record (EHR) changes led to improved compliance with cervical cancer screening and management of abnormal results in adolescent (<21 y) patients, and found that implementation of two new prompts was associated with lower rates of unindicated Pap testing in adolescents but did not improve providers choosing the correct Pap type.

Methods

  • Two EHR prompts were implemented in May 2011.
  • The first is a bright yellow alert that pops up whenever a Pap test is ordered in a patient younger than 21 years, recommending against routine screening.
  • The second was a change in wording of the Pap order form, indicating that if Pap testing is done, human papillomavirus (HPV) testing is not appropriate in this age group.

Results

  • The overall rate of Pap testing decreased after the EHR changes (86/759 [11.3%] before vs 69/1,274 [5.4%] after, P<0.0005).
  • The rate of Pap testing without a valid indication such as a 12–month follow–up of previous abnormal results also decreased (66/759 [8.7%] before vs 49/1,274 [3.8%] after, P<0.0005).
  • Most Pap tests (77%, both before and after EHR changes) were ordered with reflex HPV testing if atypical squamous cells of undetermined significance.
  • Use of the correct Pap order type (Pap alone, no HPV test) did not improve (16/86 [18.6%] vs 15/69 [22%], P=0.0857). Source